Lilly, Boehringer diabetes drug reduces cardiovascular risk in trial

[ahlam1399]

Lilly, Boehringer diabetes drug reduces cardiovascular risk in trial

Lilly, Boehringer diabetes drug reduces cardiovascular risk in trial
FRANKFURT (Reuters) - A clinical trial showed that diabetes drug Jardiance, co-promoted by Eli Lilly and Boehringer Ingelheim, reduces cardiovascular risk in patients with type 2 diabetes, Boehringer Ingelheim said in a statement on Thursday.

??????? ??????: Lilly, Boehringer diabetes drug reduces cardiovascular risk in trial || ??????: ahlam1399 || ??????: اسم منتداك

https://hameed.nwar.uk/vb

كلمات البحث

العاب ، برامج ، سيارات ، هاكات ، استايلات